Further information on QIAGEN
can be found at http://www.
About KREATECH Biotechnology
KREATECH Biotechnology B. The driving force behind the innovative "systems" approach
is the integration of biology, computation, and technology .

wellesley nucleic

QIAGEN's proprietary nucleic acid sample preparation
and handling technologies provide high reliability and efficiency in both DNA
and RNA separation and purification for molecular diagnostics applications . Efficient extraction and purification of target
nucleic acids are elements to sensitive and reliable nucleic acid testing. If you experience problems listening to
the broadcast, send an email to webmaster@vdat .org

atpases recombination

, a Netherlands holding company with subsidiaries in Germany,
the United States, Japan , the United Kingdom, Switzerland, France, Italy,
Australia, Norway, Austria, Canada, and the Netherlands believes it is the
world's leading provider of innovative enabling technologies and products for
the separation, purification and handling of nucleic acids and proteins. QIAGEN
employs approximately 1,400 people worldwide.

QIAGEN
employs approximately 1,400 people worldwide.

This category includes resources for the teaching and learning of biochemistry as a whole, for teachers, students and the general public.

atpases carbohydrates

Frank Krieg-Schneider,
Executive Director Strategic Alliances at QIAGEN.

VENLO, Netherlands, In conjunction with QIAGEN's
First Quarter 2005 Earnings release, you are invited to listen to its
conference call which will be broadcast live over the Internet on Tuesday , May
3, 2005 at 9:30 a.

Institute of Systems Biology (ISB) Adopts Kreatech Biotechnology's ULS(TM ) Nucleic Acid Labeling Technology in a Collaboration on New Assays

Nitin Baliga, Assistant Professor at the ISB.

recombination prokaryotes

qiagen.

wellesley atpases

VENLO, the Netherlands, QIAGEN GmbH,
a wholly-owned subsidiary of QIAGEN N .

mistakes proteomics

This customized kit will incorporate a specific version of QIAGEN's
well-established QIAamp (R) technology to purify DNA from specimens stored in
liquid cytology media."
About QIAGEN:
QIAGEN N.V. Such
uncertainties and risks include, but are not limited to, risks associated
with management of growth and international operations (including the effects
of currency fluctuations and risks of dependency on logistics), variability
of operating results, the commercial development of the DNA sequencing,
genomics and proteomics markets, nucleic acid-based molecular diagnostics
market, and genetic vaccination and gene therapy markets, competition, rapid
or unexpected changes in technologies, fluctuations in demand for QIAGEN's,
products (including seasonal fluctuations) , difficulties in successfully
adapting QIAGEN's products to integrated solutions and producing such
products, the ability of QIAGEN to identify and develop new products and to
differentiate its products from competitors, market acceptance of QIAGEN's
new products and the integration of acquisitions of technologies and
businesses.

proteomics subsets

V. QIAGEN's products are
sold in more than 42 countries throughout the world to academic research
markets and to leading pharmaceutical and biotechnology companies .4Kbps connection to the Internet.
"We are pleased and very proud with the fact that a renowned institute
like the Institute of Systems Biology has made the switch to our technology",
says Alexander Altink, Kreatech's CEO. ISB's goal is to unravel the mysteries of human biology and
identify strategies for predicting and preventing diseases such as cancer,
diabetes and AIDS.

acids proteomics

qiagen. For further information , refer to the discussion in reports that
QIAGEN has filed with the U. Securities and Exchange Commission (SEC).

QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its First Quarter 2005 Earnings Conference Call on the Web

What: QIAGEN N.

dogma alberts

QIAGEN has developed a comprehensive portfolio of more than 320 proprietary,
consumable products for nucleic acid and protein separation, purification and
handling, nucleic acid amplification, as well as automated instrumentation,
synthetic nucleic acid products and related services.

atpases carbohydrates

KREATECH's proprietary Universal
Linkage System (ULS(TM)) offers a reliable, robust and easy to use
non-enzymatic technology that can be applied to a broad range of biomolecules
and labeling agents.
More information on KREATECH can be accessed at http: //www.

dogma carbohydrates

(Nasdaq: QGENF, Frankfurt, Prime
Standard: QIA) today announced that they have entered into a manufacturing
and supply agreement with Roche Molecular Systems, Pleasanton , California, a
unit of Roche Diagnostics Basel, Switzerland, who will market QIAGEN's media
sample preparation kits under their AmpliLute trademark. Further information on QIAGEN
can be found at http://www., a Netherlands holding company with subsidiaries in Germany,
the United States, Japan, the United Kingdom, Switzerland , France, Italy,
Australia, Norway, Austria, Canada, and the Netherlands believes it is the
world 's leading provider of innovative enabling technologies and products for
the separation, purification and handling of nucleic acids and proteins.
Currently available kits from Kreatech are optimized for labeling of
amplified RNA for gene-expression analysis and for labeling of genomic DNA
for microarray based comparative genomic hybridization (arrayCGH). This
collaboration with the ISB will help Kreatech to position the ULS technology
in new application areas.V.

biochemistry signaling

QIAGEN's products are
sold in more than 42 countries throughout the world to academic research
markets and to leading pharmaceutical and biotechnology companies.com. - First Quarter 2005 Earnings Announcement

When: Tuesday , May 3, 2005 at 9:30 a. The labeling kits used by the ISB
include the unique purification columns (KREApure), blocking buffer
(KREAblock) and ULS bound with Dyomics' DY Dyes.

chime molecular

V.
"We are very pleased that Roche Diagnostics has selected QIAGEN nucleic
acid purification kits as a front-end preparation solution to their
amplification and detection procedure," said Dr. "Roche is a leader in
molecular diagnostics and their PCR tests are considered to be some of the
most highly sensitive and efficient molecular diagnostic testing products
available in the marketplace., a private company founded in 1990, focuses
on the creation, development, production and marketing of innovative
diagnostic and life science products. This approach
allows scientists to analyze all of the elements in a system rather than one
gene or protein at a time.
For more information about the ISB visit: http: //www.

lipids biochemistry

In
addition, QIAGEN is positioning its products for sale into developing
commercial markets , including DNA sequencing and genomics, nucleic acid-based
molecular diagnostics, and genetic vaccination and gene therapy.)

molecular acids

QIAGEN Announces Supply Agreement With Roche Molecular Systems to Provide AmpliLute Media Sample Preparation Kits

Securities Act of 1933, as amended, and Section 21E of the U.S. EDT

Where: http://www.
QIAGEN has developed a comprehensive portfolio of more than 320 proprietary,
consumable products for nucleic acid and protein separation, purification and
handling, nucleic acid amplification, as well as automated instrumentation,
synthetic nucleic acid products and related services.com.

univ alberts

m.com/goto/050305

How: Live over the Internet -- Simply log on to the Web at the
address above. Nitin Baliga's research group and is
now the preferred labeling method for both bacterial gene expression
profiling and Chip on Chip assays that have been developed at the ISB.

atpases univ

S. EDT, with Peer M.

The corresponding presentation slides are available to download in the
investor relations section of QIAGEN's website at:
http: //www.V. AMSTERDAM, The Netherlands, September 21 -- The continuing
scientific collaboration between the Institute of Systems Biology and
Kreatech's product development team has resulted in an arrangement between
Kreatech and the ISB for the use of Kreatech's commercial products.
Kreatech's platinum based "Universal Linkage System" (ULS(TM)), a
non-enzymatic way of labeling nucleic acids with detectable molecules such as
fluorophores, has been adopted by Dr. "We have been working with
this technology for a while and we like both the reproducible labeling
efficiencies as well as the one-step purification of labeled material", says
Dr. The company's quality policies
are demonstrated by the implementation of ISO 9001 (2000) and ISO 13485 (GMP
2003) guidelines.

proteomics prokaryotes

To the extent that any of the
statements contained herein relating to QIAGEN's products, markets, strategy
or operating results are forward -looking, such statements are based on
current expectations that involve a number of uncertainties and risks.

(Minimum Requirements to listen to broadcast: The RealPlayer software,
downloadable free from http://www.real.

lipids prokaryotes

nucleic apoptosis

Certain of the statements contained in this news release may be
considered forward-looking statements within the meaning of Section 27A of
the U.com/goto/050305

Contact: Jane Petrino, Noonan Russo, 212-845-4274

QIAGEN N.com.

subsets nucleic

m. Schatz, President and Chief Executive
Officer and Roland Sackers, Chief Financial Officer.QIAGEN.

atpases biochemistry

S.microsoft.kreatech. Located in Seattle, Washington, the Institute has
grown to 11 faculty and more than 170 staff members, an annual budget of more
than $25 million and an extensive network of academic and industrial partners .

rasmol univ

com/products/player/index.com and at least a
14.com
About the Institute for Systems Biology

The Institute for Systems Biology (ISB) is an internationally renowned
non-profit research institute dedicated to the study and application of
systems biology.

nucleic lipids

Securities Exchange Act of 1934, as amended.QIAGEN. In
addition, QIAGEN is positioning its products for sale into developing
commercial markets, including DNA sequencing and genomics, nucleic acid-based
molecular diagnostics , and genetic vaccination and gene therapy.html, or The
Windows Media Player, downloadable free from http://www. KREATECH is committed to achieve and maintain the
highest standards in production and Quality Control as well as in the
relationships with our customers and partners.systemsbiology.

univ proteomics

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)